Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistance
about
The potential impact of coinfection on antimicrobial chemotherapy and drug resistanceEpisensitization: Defying Time's ArrowExploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer.Tumor evolution: Linear, branching, neutral or punctuated?Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.
P2860
Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistance
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evolutionary strategy for syst ...... with suppression of resistance
@ast
Evolutionary strategy for syst ...... with suppression of resistance
@en
Evolutionary strategy for syst ...... with suppression of resistance
@nl
type
label
Evolutionary strategy for syst ...... with suppression of resistance
@ast
Evolutionary strategy for syst ...... with suppression of resistance
@en
Evolutionary strategy for syst ...... with suppression of resistance
@nl
prefLabel
Evolutionary strategy for syst ...... with suppression of resistance
@ast
Evolutionary strategy for syst ...... with suppression of resistance
@en
Evolutionary strategy for syst ...... with suppression of resistance
@nl
P2093
P2860
P356
P1433
P1476
Evolutionary strategy for syst ...... with suppression of resistance
@en
P2093
Robert A Gatenby
Susan Minton
P2860
P304
P356
10.2217/WHE.14.23
P50
P577
2014-07-01T00:00:00Z